West Pharmaceutical Services Inc. logo

West Pharmaceutical Services Inc.

WST | NYSE
Chart Builder DCF Calculator
$412.62
-$4.05 (-0.97%)
At close: Oct 30, 2026, 4:00 PM ET
$420.74
+$8.12 (+1.97%)
Pre-market: Nov 2, 2026, 7:01 AM ET

Company Profile

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Key Executives

Name Position
Eric Green Non-Independent Chair of the Board, President & Chief Executive Officer
Michel Lagarde President, CEO & Director
Devesh Mathur Senior Vice President & Chief Technology Officer
Robert W. McMahon Senior Vice President & Chief Financial Officer
Aileen Ruff-Patry President of Contract Manufacturing
Andy Polywacz President of Integrated Systems
Annette F. Favorite Chief Human Resources Officer & Senior Vice President
Chad R. Winters Vice President of Finance & Chief Accounting Officer
Don O'Callaghan President of Drug Delivery Devices
John Sweeney Vice President of Investor Relations
Kathy DePadua Senior Vice President and Chief Quality & Regulatory Officer
Michele Polinsky Vice President of Global Communications
Norman Finch Senior VP, General Counsel & Corporate Secretary
Rudy Poussot Senior Vice President of Strategy & Corporate Development
Shane Campbell SVP & Chief Proprietary Segment Officer

Latest SEC Filings

Date Type Title
Oct 02, 2026 4 Filing
Sep 15, 2026 4 Filing
Sep 10, 2026 4 Filing
Sep 10, 2026 4 Filing
Sep 10, 2026 3 Filing
Aug 12, 2026 4 Filing
Aug 06, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Jul 23, 2026 10-Q Quarterly Report
Jul 23, 2026 8-K Current Report
Jul 14, 2026 8-K Current Report
View All SEC Filings ➞
West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc. logo
Country United States
IPO Date Mar 17, 1980
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 10,800
CEO Michel Lagarde

Contact Details

530 Herman O. West Drive Exton, Pennsylvania 19341-1147 United States

Stock Details

Ticker Symbol WST
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000105770
CUSIP Number 955306105
ISIN Number US9553061055
SIC Code 3060

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.